{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:33:31Z","timestamp":1777718011682,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of EVO research funding (A special Finnish state subsidy for health science research)"},{"name":"Foundation of EVO research funding"},{"name":"Suomen Akatemia (FI)"},{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004325","name":"Signe ja Ane Gyllenbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Helsinki Research Funds"},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12884-018-1908-9","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T11:38:34Z","timestamp":1530617914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8971-2984","authenticated-orcid":false,"given":"Katja","family":"Murtoniemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia M.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaakko","family":"Matom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina","family":"Keikkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piia","family":"Vuorela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esa","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eero","family":"Kajantie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu-Katriina","family":"Pesonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"R\u00e4ikk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf-H\u00e5kan","family":"Stenman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannele","family":"Laivuori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"issue":"3","key":"1908_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130\u20137.","journal-title":"Semin Perinatol"},{"issue":"3","key":"1908_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000336662","volume":"31","author":"S Roberge","year":"2012","unstructured":"Roberge S, Villa P, Nicolaides K, Gigu\u00e8re Y, Vainio M, Bakthi A, Ebrashy A, Bujold E. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31(3):141\u20136.","journal-title":"Fetal Diagn Ther"},{"issue":"5","key":"1908_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/uog.12421","volume":"41","author":"S Roberge","year":"2013","unstructured":"Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2013;41(5):491\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1908_CR4","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/AOG.0000000000001049","volume":"126","author":"AGOC Committee Opinion No. 638","year":"2015","unstructured":"AGOC Committee Opinion No. 638. First-trimester risk assessment for early-onset preeclampsia. Obstet Gynecol. 2015;126:e25\u20137.","journal-title":"Obstet Gynecol"},{"key":"1908_CR5","doi-asserted-by":"publisher","first-page":"i1753","DOI":"10.1136\/bmj.i1753","volume":"353","author":"E Bartsch","year":"2016","unstructured":"Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753.","journal-title":"BMJ"},{"issue":"3","key":"1908_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000324320","volume":"29","author":"KH Nicolaides","year":"2011","unstructured":"Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther. 2011;29(3):183\u201396.","journal-title":"Fetal Diagn Ther"},{"issue":"11","key":"1908_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.placenta.2013.08.006","volume":"34","author":"E Keikkala","year":"2013","unstructured":"Keikkala E, Vuorela P, Laivuori H, Romppanen J, Heinonen S, Stenman UH. First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia. Placenta. 2013;34(11):1059\u201365.","journal-title":"Placenta"},{"key":"1908_CR8","doi-asserted-by":"publisher","unstructured":"Girchenko P, H\u00e4m\u00e4l\u00e4inen E, Kajantie E, Pesonen AK, Villa P, Laivuori H, R\u00e4ikk\u00f6nen K. Prediction and prevention of preeclampsia and intrauterine growth restriction (PREDO) study. Int J Epidemiol. 2016; https:\/\/doi.org\/10.1093\/ije\/dyw154 .","DOI":"10.1093\/ije\/dyw154"},{"issue":"1","key":"1908_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","volume":"120","author":"PM Villa","year":"2013","unstructured":"Villa PM, Kajantie E, R\u00e4ikk\u00f6nen K, Pesonen AK, H\u00e4m\u00e4l\u00e4inen E, Vainio M, Taipale P, Laivuori H. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO trial and a meta-analysis of randomised trials. BJOG. 2013;120(1):64\u201374.","journal-title":"BJOG"},{"issue":"2","key":"1908_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/uog.5315","volume":"32","author":"O G\u00f3mez","year":"2008","unstructured":"G\u00f3mez O, Figueras F, Fern\u00e1ndez S, Bennasar M, Mart\u00ednez JM, Puerto B, Gratac\u00f3s E. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32(2):128\u201332.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"1908_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1373\/clinchem.2010.159939","volume":"57","author":"UH Stenman","year":"2011","unstructured":"Stenman UH, Birken S, Lempi\u00e4inen A, Hotakainen K, Alfthan H. Elimination of complement interference in immunoassay of hyperglycosylated human chorionic gonadotropin. Clin Chem. 2011;57(7):1075\u20137.","journal-title":"Clin Chem"},{"issue":"1","key":"1908_CR12","first-page":"159","volume":"99","author":"ACOG Practice Bulletin No","year":"2002","unstructured":"Practice Bulletin No ACOG. 33: diagnosis and Management of Preeclampsia and Eclampsia. Obstet Gynecol. 2002;99(1):159\u201367.","journal-title":"Obstet Gynecol"},{"issue":"18","key":"1908_CR13","first-page":"1540","volume":"105","author":"J Pihkala","year":"1989","unstructured":"Pihkala J, Hakala T, Voutilainen P, Raivio K. Characteristic of recent fetal growth curves in Finland. Duodecim. 1989;105(18):1540\u20136.","journal-title":"Duodecim"},{"issue":"1","key":"1908_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"key":"1908_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"1908_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/sim.6782","volume":"35","author":"M Pavlou","year":"2016","unstructured":"Pavlou M, Ambler G, Seaman S, De Iorio M, Omar RZ. Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events. Stat Med. 2016;35(7):1159\u201377.","journal-title":"Stat Med"},{"issue":"3","key":"1908_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"3","key":"1908_CR18","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1161\/HYPERTENSIONAHA.114.03578","volume":"64","author":"LC Kenny","year":"2014","unstructured":"Kenny LC, Black MA, Poston L, Taylor R, Myers JE, Baker PN, McCowan LM, Simpson NA, Dekker GA, Roberts CT, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the screening for pregnancy endpoints (SCOPE) international cohort study. Hypertension. 2014;64(3):644\u201352.","journal-title":"Hypertension"},{"issue":"14","key":"1908_CR19","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S","volume":"17","author":"FY Hsieh","year":"1998","unstructured":"Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17(14):1623\u201334.","journal-title":"Stat Med"},{"issue":"2","key":"1908_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/jhh.2009.45","volume":"24","author":"LC Poon","year":"2010","unstructured":"Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24(2):104\u201310.","journal-title":"J Hum Hypertens"},{"issue":"11","key":"1908_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/j.1471-0528.2000.tb11657.x","volume":"107","author":"RA Odeg\u00e5rd","year":"2000","unstructured":"Odeg\u00e5rd RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. BJOG. 2000;107(11):1410\u20136.","journal-title":"BJOG"},{"issue":"8","key":"1908_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1471-0528.1994.tb13182.x","volume":"101","author":"JW Meekins","year":"1994","unstructured":"Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994;101(8):669\u201374.","journal-title":"Br J Obstet Gynaecol"},{"issue":"10","key":"1908_CR23","doi-asserted-by":"publisher","first-page":"E240","DOI":"10.1210\/jc.2010-0138","volume":"95","author":"J Guibourdenche","year":"2010","unstructured":"Guibourdenche J, Handschuh K, Tsatsaris V, Gerbaud P, Leguy MC, Muller F, Brion DE, Fournier T. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab. 2010;95(10):E240\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1908_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.placenta.2007.01.011","volume":"28","author":"LA Cole","year":"2007","unstructured":"Cole LA. Hyperglycosylated hCG. Placenta. 2007;28(10):977\u201386.","journal-title":"Placenta"},{"issue":"5","key":"1908_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/14767058.2011.591461","volume":"25","author":"E Soto","year":"2012","unstructured":"Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, Kim CJ, Chaiworapongsa T. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med. 2012;25(5):498\u2013507.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"7","key":"1908_CR26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/pd.4335","volume":"34","author":"E Keikkala","year":"2014","unstructured":"Keikkala E, Ranta JK, Vuorela P, Leinonen R, Laivuori H, V\u00e4is\u00e4nen S, Marttala J, Romppanen J, Pulkki K, Stenman UH, et al. Serum hyperglycosylated human chorionic gonadotrophin at 14-17\u2009weeks of gestation does not predict preeclampsia. Prenat Diagn. 2014;34(7):699\u2013705.","journal-title":"Prenat Diagn"},{"issue":"6","key":"1908_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1503\/cmaj.070430","volume":"178","author":"JS Cnossen","year":"2008","unstructured":"Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178(6):701\u201311.","journal-title":"CMAJ"},{"issue":"12","key":"1908_CR28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/pd.2383","volume":"29","author":"I Herraiz","year":"2009","unstructured":"Herraiz I, Arbues J, Camano I, Gomez-Montes E, Graneras A, Galindo A. Application of a first-trimester prediction model for pre-eclampsia based on uterine arteries and maternal history in high-risk pregnancies. Prenat Diagn. 2009;29(12):1123\u20139.","journal-title":"Prenat Diagn"},{"issue":"1","key":"1908_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/uog.10147","volume":"40","author":"I Herraiz","year":"2012","unstructured":"Herraiz I, Escribano D, Gomez-Arriaga PI, Hernindez-Garcia JM, Herraiz MA, Galindo A. Predictive value of sequential models of uterine artery Doppler in pregnancies at high risk for pre-eclampsia. Ultrasound Obstet Gynecol. 2012;40(1):68\u201374.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"1908_CR30","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","volume":"214","author":"N O'Gorman","year":"2016","unstructured":"O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1\u2013e12.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1908_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/pd.4519","volume":"35","author":"F Crovetto","year":"2015","unstructured":"Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Dominguez C, et al. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors. Prenat Diagn. 2015;35(2):183\u201391.","journal-title":"Prenat Diagn"},{"issue":"1","key":"1908_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","volume":"33","author":"R Akolekar","year":"2013","unstructured":"Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8\u201315.","journal-title":"Fetal Diagn Ther"},{"issue":"6","key":"1908_CR33","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1161\/HYPERTENSIONAHA.113.02664","volume":"63","author":"L Myatt","year":"2014","unstructured":"Myatt L, Redman CW, Staff AC, Hansson S, Wilson ML, Laivuori H, Poston L, Roberts JM, CoLaboratory GP. Strategy for standardization of preeclampsia research study design. Hypertension. 2014;63(6):1293\u2013301.","journal-title":"Hypertension"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-018-1908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-018-1908-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-018-1908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:23:44Z","timestamp":1604535824000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-018-1908-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1186\/s12884-018-1908-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"19 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Ethics Committee of the Helsinki and Uusimaa Hospital District approved the study and written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Consulting fees from Roche Diagnostics (Villa). Finox Biotech Nordics AB, unconditional support for the Meeting of the Nordic Expert Group (Laivuori).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"279"}}